Literature DB >> 26260899

Neurocognitive impairment in the deficit subtype of schizophrenia.

Gagan Fervaha1,2, Ofer Agid3,4,5, George Foussias3,4,5, Ishraq Siddiqui3,4, Hiroyoshi Takeuchi3,5, Gary Remington3,4,5.   

Abstract

Schizophrenia is a heterogeneous disorder characterized by numerous diverse signs and symptoms. Individuals with prominent, persistent, and idiopathic negative symptoms are thought to encompass a distinct subtype of schizophrenia. Previous work, including studies involving neuropsychological evaluations, has supported this position. The present study sought to further examine whether deficit patients are cognitively distinct from non-deficit patients with schizophrenia. A comprehensive neurocognitive battery including tests of verbal memory, vigilance, processing speed, reasoning, and working memory was administered to 657 patients with schizophrenia. Of these, 144 (22 %) patients were classified as deficit patients using a proxy identification method based on severity, persistence over time, and possible secondary sources (e.g., depression) of negative symptoms. Deficit patients with schizophrenia performed worse on all tests of cognition relative to non-deficit patients. These patients were characterized by a generalized cognitive impairment on the order of about 0.4 standard deviations below that of non-deficit patients. However, when comparing deficit patients to non-deficit patients who also present with negative symptoms, albeit not enduring or primary, no group differences in cognitive performance were found. Furthermore, a discriminant function analysis classifying patients into deficit/non-deficit groups based on cognitive scores demonstrated only 62.3 % accuracy, meaning over one-third of individuals were misclassified. The deficit subtype of schizophrenia is not markedly distinct from non-deficit schizophrenia in terms of neurocognitive performance. While deficit patients tend to have poorer performance on cognitive tests, the magnitude of this effect is relatively modest, translating to over 70 % overlap in scores between groups.

Entities:  

Keywords:  Amotivation; Avolition–apathy; Deficit syndrome; Neurocognition; Persistent negative symptoms; Psychotic disorder

Mesh:

Year:  2015        PMID: 26260899     DOI: 10.1007/s00406-015-0629-6

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  59 in total

1.  Baseline neurocognitive deficits in the CATIE schizophrenia trial.

Authors:  Richard S E Keefe; Robert M Bilder; Philip D Harvey; Sonia M Davis; Barton W Palmer; James M Gold; Herbert Y Meltzer; Michael F Green; Del D Miller; Jose M Canive; Lawrence W Adler; Theo C Manschreck; Marvin Swartz; Robert Rosenheck; Diana O Perkins; Trina M Walker; T Scott Stroup; Joseph P McEvoy; Jeffrey A Lieberman
Journal:  Neuropsychopharmacology       Date:  2006-04-19       Impact factor: 7.853

2.  Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task.

Authors:  A C Lahti; H H Holcomb; D R Medoff; M A Weiler; C A Tamminga; W T Carpenter
Journal:  Am J Psychiatry       Date:  2001-11       Impact factor: 18.112

3.  General and domain-specific neurocognitive impairments in deficit and non-deficit schizophrenia.

Authors:  János M Réthelyi; Pál Czobor; Patrícia Polgár; Beatrix Mersich; Sára Bálint; Eva Jekkel; Krisztina Magyar; Agnes Mészáros; Agnes Fábián; István Bitter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-07-27       Impact factor: 5.270

4.  Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome.

Authors:  C A Tamminga; G K Thaker; R Buchanan; B Kirkpatrick; L D Alphs; T N Chase; W T Carpenter
Journal:  Arch Gen Psychiatry       Date:  1992-07

5.  A depression rating scale for schizophrenics.

Authors:  D Addington; J Addington; B Schissel
Journal:  Schizophr Res       Date:  1990 Jul-Aug       Impact factor: 4.939

6.  Relationship of cognition and psychopathology to functional impairment in schizophrenia.

Authors:  Somaia Mohamed; Robert Rosenheck; Marvin Swartz; Scott Stroup; Jeffrey A Lieberman; Richard S E Keefe
Journal:  Am J Psychiatry       Date:  2008-05-01       Impact factor: 18.112

7.  Specificity of the Calgary Depression Scale for schizophrenics.

Authors:  D Addington; J Addington; E Maticka-Tyndale
Journal:  Schizophr Res       Date:  1994-02       Impact factor: 4.939

8.  Deficit and nondeficit forms of schizophrenia: neuropsychological evaluation.

Authors:  A M Wagman; D W Heinrichs; W T Carpenter
Journal:  Psychiatry Res       Date:  1987-12       Impact factor: 3.222

9.  How to find the way out from four rooms? The learning of "chaining" associations may shed light on the neuropsychology of the deficit syndrome of schizophrenia.

Authors:  Patricia Polgár; Márta Farkas; Orsolya Nagy; Oguz Kelemen; János Réthelyi; István Bitter; Catherine E Myers; Mark A Gluck; Szabolcs Kéri
Journal:  Schizophr Res       Date:  2007-08-10       Impact factor: 4.939

10.  White matter alterations in deficit schizophrenia.

Authors:  Laura M Rowland; Elena A Spieker; Alan Francis; Peter B Barker; William T Carpenter; Robert W Buchanan
Journal:  Neuropsychopharmacology       Date:  2008-12-03       Impact factor: 7.853

View more
  9 in total

1.  Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid.

Authors:  Buranee Kanchanatawan; Sunee Sirivichayakul; Kiat Ruxrungtham; André F Carvalho; Michel Geffard; Heidi Ormstad; George Anderson; Michael Maes
Journal:  Mol Neurobiol       Date:  2017-02-08       Impact factor: 5.590

2.  Neural substrate of unrelenting negative symptoms in schizophrenia: a longitudinal resting-state fMRI study.

Authors:  Mingli Li; Wei Deng; Tushar Das; Yinfei Li; Liansheng Zhao; Xiaohong Ma; Yingcheng Wang; Hua Yu; Xiaojing Li; Ya-Jing Meng; Qiang Wang; Lena Palaniyappan; Tao Li
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-11-11       Impact factor: 5.270

3.  Affective modulation of target detection in deficit and non-deficit schizophrenia.

Authors:  Pamela DeRosse; Chaya B Gopin; Anita D Barber; Anil K Malhotra
Journal:  Schizophr Res       Date:  2018-08-17       Impact factor: 4.939

4.  Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway.

Authors:  Buranee Kanchanatawan; Sunee Sirivichayakul; Supaksorn Thika; Kiat Ruxrungtham; André F Carvalho; Michel Geffard; George Anderson; Cristiano Noto; Rada Ivanova; Michael Maes
Journal:  Metab Brain Dis       Date:  2017-03-03       Impact factor: 3.584

5.  Polygenic Risk Scores for Subtyping of Schizophrenia.

Authors:  Jingchun Chen; Travis Mize; Jain-Shing Wu; Elliot Hong; Vishwajit Nimgaonkar; Kenneth S Kendler; Daniel Allen; Edwin Oh; Alison Netski; Xiangning Chen
Journal:  Schizophr Res Treatment       Date:  2020-07-23

6.  Deconstructing Negative Symptoms in Individuals at Clinical High-Risk for Psychosis: Evidence for Volitional and Diminished Emotionality Subgroups That Predict Clinical Presentation and Functional Outcome.

Authors:  Tina Gupta; Henry R Cowan; Gregory P Strauss; Elaine F Walker; Vijay A Mittal
Journal:  Schizophr Bull       Date:  2021-01-23       Impact factor: 9.306

7.  EPICOG-SCH: A brief battery to screen cognitive impact of schizophrenia in stable outpatients.

Authors:  Silvia Zaragoza Domingo; Julio Bobes; Maria-Paz García-Portilla; Claudia Morralla
Journal:  Schizophr Res Cogn       Date:  2017-03-18

8.  The relationship between moderate-to-vigorous physical activity and executive function among individuals with schizophrenia: differences by illness duration.

Authors:  Viviane Grassmann; Mehala Subramaniapillai; Mark Duncan; Kelly Arbour-Nicitopoulos; Guy E Faulkner
Journal:  Braz J Psychiatry       Date:  2017-03-30       Impact factor: 2.697

9.  Psychopathology and Integrity of the Superior Longitudinal Fasciculus in Deficit and Nondeficit Schizophrenia.

Authors:  Piotr Podwalski; Ernest Tyburski; Krzysztof Szczygieł; Krzysztof Rudkowski; Katarzyna Waszczuk; Wojciech Andrusewicz; Jolanta Kucharska-Mazur; Anna Michalczyk; Monika Mak; Katarzyna Cyranka; Błażej Misiak; Leszek Sagan; Jerzy Samochowiec
Journal:  Brain Sci       Date:  2022-02-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.